FDA OKs Trials for Nexalin's Sleep and Anxiety Therapy Headset
The FDA has agreed on the design for Nexalin's planned clinical studies of the Gen-3 HALO Clarity, targeting insomnia and anxiety.
Stay updated with breaking news from Technology Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA has agreed on the design for Nexalin's planned clinical studies of the Gen-3 HALO Clarity, targeting insomnia and anxiety.
Eagle Asset Management Inc. trimmed its holdings in shares of Align Technology, Inc. (NASDAQ:ALGN – Free Report) by 0.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 266,997 shares of the medical equipment provider’s stock after selling 2,547 shares during the period. Eagle Asset Management […]
Eagle Asset Management Inc. lowered its position in Align Technology, Inc. (NASDAQ:ALGN – Free Report) by 0.9% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 266,997 shares of the medical equipment provider’s stock after selling 2,547 shares during the quarter. Eagle Asset Management Inc.’s holdings in Align Technology were worth $73,157,000 at the […]
Evoke Wealth LLC purchased a new stake in shares of Align Technology, Inc. (NASDAQ:ALGN – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 4,972 shares of the medical equipment provider’s stock, valued at approximately $1,362,000. A number of […]
RLX Technology Inc. Q1 2024 Earnings Conference Call May 17, 2024 8:00 AM ET. Executives Sam...